Those with opioid use disorder, polysubstance use less likely to initiate MOUD treatment

Individuals with opioid use disorder and polysubstance use were less likely to initiate treatment with buprenorphine and naltrexone than those without polysubstance use, according to a study published in JAMA Network Open.
“Despite a higher likelihood of treatment discontinuation and overdose, polysubstance use in individuals with opioid use disorder is understudied and undertreated,” Kevin Y. Xu, MD, MPH, of the health and behavior research center in the department of psychiatry at Washington University School of Medicine, and colleagues wrote.
Researchers sought to examine

Individuals with opioid use disorder and polysubstance use were less likely to initiate treatment with buprenorphine and naltrexone than those without polysubstance use, according to a study published in JAMA Network Open.
“Despite a higher likelihood of treatment discontinuation and overdose, polysubstance use in individuals with opioid use disorder is understudied and undertreated,” Kevin Y. Xu, MD, MPH, of the health and behavior research center in the department of psychiatry at Washington University School of Medicine, and colleagues wrote.
Researchers sought to examine